6185 — Cansino Biologics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapFalling Star

Annual balance sheet for Cansino Biologics, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	7,783	5,947	4,120	3,195	2,628
Net Total Accounts Receivable
Net Total Receivables	631	1,106	697	793	847
Total Inventory
Total Other Current Assets
Total Current Assets	9,290	7,730	5,181	4,282	3,839
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2,317	3,179	3,134	2,748	2,713
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	11,874	11,469	9,319	7,958	7,178
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2,875	2,942	2,592	1,772	1,082
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	3,879	4,721	4,044	3,048	2,224
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	7,995	6,748	5,275	4,910	4,954
Total Liabilities & Shareholders' Equity	11,874	11,469	9,319	7,958	7,178
Total Common Shares Outstanding